Naveen Karkada

Naveen Karkada

GlaxoSmithKline - Needham / United Kingdom
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4371047
-
person_outline Naveen Karkada's MOST POPULAR ARTICLES
1-) Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind …CM Wheeler, SR Skinner, MR Del Rosario-Raymundo, SM Garland, ...The Lancet infectious diseases 16 (10), 1154-1168, 20161752016
2-) Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human …B Cheuvart, KM Neuzil, AD Steele, N Cunliffe, SA Madhi, N Karkada, ...Human vaccines & immunotherapeutics 10 (2), 505-511, 2014552014
3-) A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 yearsTF Schwarz, LM Huang, A Valencia, F Panzer, CH Chiu, A Decreux, ...Human vaccines & immunotherapeutics 15 (7-8), 1970-1979, 2019542019
4-) Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trialFC Zhu, SY Hu, Y Hong, YM Hu, X Zhang, YJ Zhang, QJ Pan, WH Zhang, ...Cancer medicine 8 (14), 6195-6211, 2019542019
5-) Incidence of rotavirus gastroenteritis by age in African, Asian and European children: relevance for timing of rotavirus vaccinationAD Steele, SA Madhi, NA Cunliffe, T Vesikari, KB Phua, FS Lim, ...Human vaccines & immunotherapeutics 12 (9), 2406-2412, 2016542016